Poland - Otwock: Pharmaceutical products

Release

ID
ocds-pyfy63:2023-614908:2023-614908
Date
2023-10-11
Language
PL
Tags
tender

Release in JSON

Process

ID (OCID)
ocds-pyfy63:2023-614908
Releases
2023-10-11 (ocds-pyfy63:2023-614908:2023-614908)

Releases in JSON

Tender

Title
Poland - Otwock: Pharmaceutical products
Award criteria
priceOnly
Award criteria details
Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price
Award period
2023-11-15 - ?
Eligibility criteria
Suitability:

Zamawiający nie stawia warunku w powyższym zakresie

Economic/financial eligibility:

Zamawiający nie stawia warunku w powyższym zakresie

Technical/professional eligibility:

Zamawiający uzna warunek za spełniony, jeżeli Wykonawca będzie posiadał ważną koncesję/ zezwolenie Głównego Inspektora Farmaceutycznego na prowadzenie hurtowni farmaceutycznej lub składu konsygnacyjnego, zawierające uprawnienia w zakresie obrotu produktami leczniczymi, a w przypadku producenta - zezwolenie na produkcję, jeżeli wymagane są przepisami prawa.
Main procurement category
goods
Procurement method
open
Procurement method details
Open procedure
Tender period
2023-10-11 - 2023-11-15
Value
12 535 284.15 PLN
Minimum value
12 535 284.15 PLN

Tender item

ID
ocds-pyfy63:2023-614908:obj:1
Classification
CPV / 33600000
Description
Atezolizumab

Tender item

ID
ocds-pyfy63:2023-614908:obj:2
Classification
CPV / 33600000
Description
Brigatinib

Tender item

ID
ocds-pyfy63:2023-614908:obj:3
Classification
CPV / 33600000
Description
Carboplatyna

Tender item

ID
ocds-pyfy63:2023-614908:obj:4
Classification
CPV / 33600000
Description
Cyclophosphamid

Tender item

ID
ocds-pyfy63:2023-614908:obj:5
Classification
CPV / 33600000
Description
Docetaxel

Tender item

ID
ocds-pyfy63:2023-614908:obj:6
Classification
CPV / 33600000
Description
Doxorubcyna

Tender item

ID
ocds-pyfy63:2023-614908:obj:7
Classification
CPV / 33600000
Description
Durvalumab

Tender item

ID
ocds-pyfy63:2023-614908:obj:8
Classification
CPV / 33600000
Description
Gemcitabine

Tender item

ID
ocds-pyfy63:2023-614908:obj:9
Classification
CPV / 33600000
Description
Ondaserton

Tender item

ID
ocds-pyfy63:2023-614908:obj:10
Classification
CPV / 33600000
Description
Peclitaxel

Tender item

ID
ocds-pyfy63:2023-614908:obj:11
Classification
CPV / 33600000
Description
Pembrolizumab

Tender item

ID
ocds-pyfy63:2023-614908:obj:12
Classification
CPV / 33600000
Description
Pemetrexed

Tender item

ID
ocds-pyfy63:2023-614908:obj:13
Classification
CPV / 33600000
Description
Topotecan

Tender item

ID
ocds-pyfy63:2023-614908:obj:14
Classification
CPV / 33600000
Description
Vinorelbina

Parties

Roles
buyer
Organization name
Mazowieckie Centrum Leczenia Chorób Płuc iGruźlicy
Street address
ul.Narutowicza 80
Locality
Otwock
Postal code
05-400
Country
PL
Contact name
Hanna Cichecka
E-mail
zampub@otwock-szpital.pl
Phone
+48 3446426
Fax
+48 3446426
Website
Link

Organization data Organization in JSON